Tangent Medical Technologies

company

About

Tangent Medical Technologies provides intravenous catheters and associated products for the improvement of infusion therapy.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$8.62M
Industries
Health Care,Manufacturing,Medical Device
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

Tangent Medical Technologies, a development stage medical device company, was founded in Ann Arbor in 2009 based on technology exclusively licensed from the University of Michigan's Medical Innovation Center. The Company's mission is to improve infusion therapy for patients and healthcare workers with its proprietary, intravenous catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The Company expects to begin generating commercial revenues from its lead product, the NovaCath™ Closed IV Catheter System, in 2012.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$8.62M
Tangent Medical Technologies has raised a total of $8.62M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2012 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2012 Series B $8.62M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Tangent Medical Technologies is funded by 1 investors. University of Michigan Investment in New Technologies Fund are the most recent investors.
Investor Name Lead Investor Funding Round
University of Michigan Investment in New Technologies Fund Series B